New computer model aims to make cancer bone implants safer and more effective
NCT ID NCT07171996
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests a new way to plan radioactive seed implants for people with cancer that has spread to the bones. The new method uses a computer model to help doctors place the seeds more precisely, aiming to improve pain relief and lower the risk of bone fractures or seeds moving. The trial will compare this new planning method to the standard approach in 150 participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radioactive seed implantation (I-125)
What this could lead to
If successful, this planning method could improve pain relief and reduce bone fractures and other complications for people with cancer that has spread to the bones.
What could go wrong
This is an early-stage trial testing a new planning approach, not a new treatment. The method may not prove better than standard planning, and results may not apply to all patients or cancer types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE METASTASES IN SUBJECTS WITH ADVANCED CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The 960 Hospital of the People's Liberation Army of China
RECRUITINGJinan, Shandong, 250031, China
Contact Phone: •••-•••-•••• Email: •••••@•••••